THE SCIENCE AND PROMISE OF PHOTOBIOMODULATION

IT’S TIME FOR HEALTHCARE TO SEE THE LIGHT

THURSDAY, OCTOBER 11, 2018 | 2:00 – 3:00 p.m. (Concluded)

CONGRESSIONAL BRIEFING
2360 Rayburn House Office Building

RESERVE MY SEAT

Be quick, seating is limited.

ENDING OPIOID USE

100 million adults in the US affected by chronic pain
$504 billion per year health care cost and lost productivity associated with pain
49,000 deaths from all opioids in 2017
19,000 deaths from prescribed opioid drugs in 2017
Consumption is going down but the deaths and costs are still rising
The FDA is committed to finding alternative solutions, but what?

PHOTOBIOMODULATION (PBM)

The use of low dose laser therapy, termed photobiomodulation (PBM) therapy, has been well documented over many years. More than 500 Randomised controlled clinical trials (RCTs) and over 4,000 laboratory studies have explored the mechanism of action and dose response. Many scientists and doctors believe that PBM will become the standard of care for many acute, painful, non-healing or degenerative medical conditions.

We have assembled recognized pioneers in PBM who will present an overview of the treatment, its molecular mechanisms, results from clinical trials, and the potential impact of this technology on the health and productivity of the United States of America.

OUR SPEAKERS

James Carroll

Founder and CEO at THOR Photomedicine Ltd

James has been working on photobiomodulation (PBM) for over 30 years. He is a recognised authority on PBM dose, dose rate effects and the measurement and reporting of parameters. He has written or co-authored 18 academic papers (9 with Harvard University) and three books on Laser Photobiomodulation. He is the Biomedical Optics Society conference chair, Fellow of The Royal Society of Medicine, and recently presented Photobiomodulation to the United Nations Global Health Impact Forum.

Praveen Arany

BDS, MDS, MMSc, PhD, University at Buffalo, New York

Dr. Arany currently holds various key leadership positions including Immediate Past-President of the North American Association for Photobiomodulation Therapy (NAALT) and current President-Elect of the World Association of Laser Therapy (WALT). His primary research focuses on the molecular mechanisms and clinical translation of photobiomodulation therapy. Dr Arany is also an Assistant Professor, Oral Biology and Biomedical Engineering, University at Buffalo, NY.

Annette Quinn

RN, MSN, Program Director of Radiation Oncology at UPMC, Hillman Cancer Center, Pittsburgh

Annette Quinn RN, MSN has 25+ years of experience in oncology nursing and has numerous publications in the field of oral mucositis. Four years ago, Annette launched PBM for oral mucositis in the department of radiation oncology and has since treated over 800 patients for this debilitating side effect of cancer therapy. She is currently the Program Manager for Radiosurgery at the University of Pittsburgh Cancer Centers

PARTICIPATING & SPONSORING ORGANIZATIONS

Shepherd University
University of Buffalo
University of Pittsburgh Medical Center (UPMC)- Hillman Cancer Center
Academy of Laser Dentistry (ALD)
Alliance for Science & Technology Research in America (ASTRA)
Color of STEM
Federation of American Societies for Experimental Biology (FASEB)
International Society for Optics & Photonics (SPIE)
Council of Scientific Society Presidents (CSSP)

Washington Institute For Dentistry & Laser Surgery
C3 Think Tank
Net Generation of Youth
North American Association for Photobiomodulation Therapy
The Optical Society (OSA)
Photobiomodulation Foundation
Science-Engineering-Technology Working Group (SETWG)
Technology Education Institute (TEI)
THOR Photomedicine Ltd
World Association for Laser Therapy (WALT)

STAY INFORMED

Sign up below to stay informed about this event and latest news about PBM.

THE VENUE

Committee on Small Business
2360 Rayburn House Office Building

ENQUIRIES

If you have any questions about this event, or about Photobiomodulation systems,
please contact us using the form below.